Valuation: Stem Cells Spin S.A.

Market Cap	16.53M 4.42M 3.86M 3.54M 3.3M 6.26M 420M 6.37M 42.66M 206M 16.58M 16.22M 711M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	16.62M 4.44M 3.88M 3.56M 3.32M 6.3M 423M 6.4M 42.88M 207M 16.67M 16.3M 714M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	14.73%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-16	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
14/08/23	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	01/01/2017

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	28/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	15/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	0.00%	0.00%	+72.41%	+12.36%	4.42M
LONZA GROUP AG	+0.21%	+5.10%	+1.04%	+5.85%	49.15B
REVOLUTION MEDICINES, INC.	+0.92%	+6.21%	+408.85%	+607.44%	40.23B
IQVIA HOLDINGS INC.	+1.89%	+11.06%	+25.75%	-7.89%	34.55B
BEONE MEDICINES AG	+2.38%	+8.10%	+21.83%	+66.94%	33.09B
CELLTRION, INC.	+1.20%	+2.02%	+9.79%	+32.43%	25.19B
ASCENDIS PHARMA A/S	+2.51%	+4.94%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+2.58%	+7.24%	+71.03%	+132.17%	15.92B
EUROFINS SCIENTIFIC SE	+0.12%	+0.46%	+13.54%	+18.96%	13.83B
ICON PUBLIC LIMITED COMPANY	-1.14%	+7.52%	+14.75%	-30.83%	13.26B
Average	+1.06%	+5.79%	+71.00%	+93.05%	24.23B
Weighted average by Cap.	+1.18%	+6.73%	+88.23%	+130.73%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-14 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
02/07/26	PLN 0.4000	0.00%	16,104
01/07/26	PLN 0.4000	0.00%	200
30/06/26	PLN 0.4000	0.00%	200
29/06/26	PLN 0.4000	0.00%	100
26/06/26	PLN 0.4000	0.00%	100

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. Other stock markets 02/07/2026			5-day change	1st Jan Change
0.4000 ^PLN	0.00%		0.00%	-1.48%

1 month	+5.26%
3 months	+11.11%
6 months	-5.66%
Current year	-1.48%

1 week	0.4	0.4
1 month	0.37	0.44
Current year	0.33	0.48
1 year	0.22	0.52
3 years	0.14	0.82
5 years	0.14	1.23
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.5K 12.67K 11.63K 10.85K 20.57K 1.38M 20.91K 140K 677K 54.44K 53.25K 2.33M	65.74K 17.56K 15.34K 14.09K 13.14K 24.91K 1.67M 25.33K 170K 820K 65.92K 64.49K 2.82M
Net income	-520K -139K -121K -111K -104K -197K -13.23M -200K -1.34M -6.49M -522K -510K -22.36M	-526K -140K -123K -113K -105K -199K -13.36M -203K -1.36M -6.56M -527K -516K -22.59M
Net Debt	69.28K 18.5K 16.17K 14.85K 13.85K 26.25K 1.76M 26.69K 179K 864K 69.48K 67.97K 2.98M	84.58K 22.59K 19.74K 18.13K 16.9K 32.05K 2.15M 32.59K 218K 1.05M 84.83K 82.98K 3.63M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates